BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 16, 2010
View Archived Issues
Clinical data support potential of rufinamide for neuropathic pain
Read More
Cypher sirolimus-eluting stent superior to Endeavor zotarolimus-eluting stent in phase III trial
Read More
BT-061 improves psoriasis in double-blind trial
Read More
New fatty-acid amide hydrolase 1 inhibitor JNJ-40355003 has preclinical analgesic effects
Read More
Boehringer Ingelheim claims new bradykinin B1 receptor antagonists
Read More
FDA grants orphan drug status for BDM-E in retinitis pigmentosa
Read More
GSK presents new prostanoid DP1 receptor antagonists
Read More
NicOx and Merck & Co. expand license agreement for new NO donors
Read More
Mimetica describes new melanocortin MC1 receptor agonists
Read More
Galderma claims new inhibitors of ACAT-1
Read More
Micrus Endovascular stockholders approve merger with Johnson & Johnson
Read More
Respiratorius describes new bronchorelaxants
Read More
FDA approves Savient Pharmaceuticals' pegloticase for gout
Read More
Eisai claims new inhibitors of beta-amyloid peptide production
Read More
Synta Pharma expands phase II STA-9090 trial in NSCLC
Read More
BioCryst presents data from forodesine oncology studies
Read More
GTx-758 induces medical castration in phase II trial
Read More
Neurocrine reports data on GSK-561679 in major depressive disorder
Read More
Mochida Pharmaceutical files NDA in Japan for escitalopram
Read More
FDA grants fast track status for ARC-4558 in diabetes-associated pain
Read More
Pepscan Therapeutics and Tibotec form research collaboration
Read More
NexMed changes name to Apricus Biosciences
Read More
FDA extends review date for AstraZeneca's Brilinta NDA in ACS
Read More
FDA accepts Sanofi Pasteur's sBLA for Fluzone vaccine
Read More
BTG initiates first of three phase III studies of Varisolve in U.S.
Read More